We are delighted to announce that this month, American Health Research, in collaboration with Vitaccess, have launched the investigator-initiated AHR CB study.

The study is designed to help researchers learn how Mucinex® could be used as a long-term treatment to benefit patients with stable chronic bronchitis (SCB).
US-based adults (40 years or older) with a confirmed diagnosis of SCB are able to join the study. Participants will complete surveys on their condition and its treatment via the Vitaccess Real platform™, which can be accessed on their own phone, tablet, or PC.
For more information on the study, including how to join, see clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT05843669
AHR CB study
Skip to content